Sefton A - Search Results

1

An extended genotyping framework for Salmonella enterica serovar Typhi, the cause of human typhoid.

Wong VK, Baker S, Connor TR, Pickard D, Page AJ, Dave J, Murphy N, Holliman R, Sefton A, Millar M, Dyson ZA, Dougan G, Holt KE; International Typhoid Consortium. Wong VK, et al. Among authors: sefton a. Nat Commun. 2016 Oct 5;7:12827. doi: 10.1038/ncomms12827. Nat Commun. 2016. PMID: 27703135 Free PMC article.

2

Enteric fever and its impact on returning travellers.

Dave J, Sefton A. Dave J, et al. Among authors: sefton a. Int Health. 2015 May;7(3):163-8. doi: 10.1093/inthealth/ihv018. Epub 2015 Mar 24. Int Health. 2015. PMID: 25808163 Review.

3

Trends in antibiotic susceptibility of enteric fever isolates in East London.

Dave J, Sefton A, de Pinna E, Woodford N, Meade R, Jordan M, Grant K, Holliman R, Millar M. Dave J, et al. Among authors: sefton a. Travel Med Infect Dis. 2015 May-Jun;13(3):230-4. doi: 10.1016/j.tmaid.2015.04.001. Epub 2015 Apr 23. Travel Med Infect Dis. 2015. PMID: 25964222

4

East London experience with enteric fever 2007-2012.

Dave J, Millar M, Maxeiner H, Freedman J, Meade R, Rosmarin C, Jordan M, Andrews N, Holliman R, Sefton A. Dave J, et al. Among authors: sefton a. PLoS One. 2015 Mar 19;10(3):e0120926. doi: 10.1371/journal.pone.0120926. eCollection 2015. PLoS One. 2015. PMID: 25790017 Free PMC article.

5

What were the risk factors and trends in antimicrobial resistance for enteric fever in London 2005-2012?

Dave J, Warburton F, Freedman J, de Pinna E, Grant K, Sefton A, Crawley-Boevey E, Godbole G, Holliman R, Balasegaram S. Dave J, et al. Among authors: sefton a. J Med Microbiol. 2017 Jun;66(6):698-705. doi: 10.1099/jmm.0.000484. J Med Microbiol. 2017. PMID: 28590238

6

Epidemiology, antibiotic resistance trends and the cost of enteric fever in East London, 2005-2010.

Reddy S, Rangaiah J, Addiman S, Wareham D, Wilson P, Sefton A. Reddy S, et al. Among authors: sefton a. Travel Med Infect Dis. 2011 Jul;9(4):206-12. doi: 10.1016/j.tmaid.2011.03.003. Epub 2011 Jun 1. Travel Med Infect Dis. 2011. PMID: 21636325

7

The impact of resistance on the management of urinary tract infections.

Sefton AM. Sefton AM. Int J Antimicrob Agents. 2000 Dec;16(4):489-91. doi: 10.1016/s0924-8579(00)00282-x. Int J Antimicrob Agents. 2000. PMID: 11118864

8

Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.

Williams JD, Maskell JP, Shain H, Chrysos G, Sefton AM, Fraser HY, Hardie JM. Williams JD, et al. Among authors: sefton am. J Antimicrob Chemother. 1992 Jul;30(1):27-37. doi: 10.1093/jac/30.1.27. J Antimicrob Chemother. 1992. PMID: 1331019

9

The prevention of antibiotic resistance during treatment.

Williams JD, Sefton AM. Williams JD, et al. Among authors: sefton am. Infection. 1999;27 Suppl 2:S29-31. doi: 10.1007/BF02561667. Infection. 1999. PMID: 10885824 Review.

10

Predominance of resistant oral streptococci in saliva and the effect of a single course of josamycin or erythromycin.

Maskell JP, Sefton AM, Cannell H, Kerawala C, Seymour A, Sun ZM, Williams JD. Maskell JP, et al. Among authors: sefton am. J Antimicrob Chemother. 1990 Oct;26(4):539-48. doi: 10.1093/jac/26.4.539. J Antimicrob Chemother. 1990. PMID: 2254223

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters